EPHX2 and depressive symptom measurement: Therefore, sEH is considered as a potential target for the treatment of psychiatric disorders such as depression and bipolar disorder, whose mechanisms are related to metabolic, inflammatory, and vascular factors [55,57,58,63] (Table 1 and Table 2).